UnknownNot Applicable

Effectiveness of Holmium and Thulium Lasers With Ureteroscopy for Urinary Lithiasis

200 participantsStarted 2021-05

Plain-language summary

Holmium laser is the current gold standard for lithotripsy on urinary lithiasis, while Thulium is brand new. The latter has been released in July 2020 in Europe, and only in-vitro studies have been published. The aim of this study is to compare the stone free rate in ureteroscopy, for all consecutive patients treated with laser fragmentation, between both Holmium and Thulium lasers. The costs and complications will also be studied.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * renal ou ureteral stone confirmed by an abdominal and pelvic computed tomography * treatment with rigid or flexible ureteroscopy * laser lithotripsy during the procedure * bacteriological examination of urine (sterile, bacterial colonization or treated by antibiotics) Exclusion Criteria: * non-use of laser for stone lithotripsy * pregnant women * under 18 years old * refusal to give informed consent * urinary malformation

What they're measuring

Stone free rate

Timeframe: Three months after surgery

Trial details

NCT IDNCT04871984

SponsorUniversity Hospital, Angers

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2021-05

Contact for this trial

Pierre BIGOT, MD-PhD

0241355830 PiBigot@chu-angers.fr

View on ClinicalTrials.gov More Renal Stone trials